I would like to speculate on the possibility of a DuPont acquisition. Zeneca Group PLC (ZEN, $8.6 billion), (headquartered in London, maybe Nigel can comment more easily than I), has been considered a takeover candidate for a while now because of its potential complementary capabilities in the agrochemical and seeds arena and its large portfolio of drugs. DuPont and Monsanto are most frequently suggested as the potential buyers, and with Monsanto spending $4.4 billion in acquisitions recently, I thought that perhaps DuPont might be interested.
ZEN has recently split, 3 for 1 I believe, and has dropped a bit after the split. I don't own any ZEN, a friend asked me to check it out because of a breast cancer drug that they are trying to develop, and she was interested in investing for that reason.
I have more details if desired.
Filbert |
